{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:59:24Z","timestamp":1785347964498,"version":"3.55.0"},"reference-count":58,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":209,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014051","name":"Menzies Institute for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001249","name":"University of Tasmania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pain Research and Management"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Individuals with multiple sclerosis (MS) often use multiple medications, but evidence comparing their effectiveness is scarce. This study aims to (a) describe pain medication use and perceived effectiveness, (b) identify factors associated with the total number of pain medications, (c) explore the reasons for stopping and (d) use qualitative data to explore the lived experience of PwMS in relation to pain medication effectiveness and reasons for stopping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Participants from the Australian MS Longitudinal Study completed a pain survey in 2021 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091691); 26 participants self\u2010nominated to participate in focus groups. Participants with regular pain were asked which pain medications they used, to what extent the medications reduced pain, which medications they stopped using and the reasons for stopping. Quantitative data were analysed using descriptive statistics; negative binomial regression was used to determine factors associated with the total number of medications. Qualitative data were analysed using thematic analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 899 participants with regular pain, 87.3% were using pain medication. In terms of perceived effectiveness, 62.3% of all reported medications resulted in \u2018much improvement\u2019, \u2018very much improvement\u2019 or \u2018complete pain relief\u2019. The medications commonly reported to be effective were opioid\u2010containing medications, cannabinoids, antimigraine medications, a combination of paracetamol and nonsteroidal anti\u2010inflammatory drug (NSAID) products and sedatives. Having more pain types, greater pain severity, being female and greater disability (all\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.05) were associated with taking a higher number of medications. Common reasons for stopping a medication were side effects and ineffectiveness. Qualitative data supported the quantitative findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most people with pain used medications, and the effectiveness was acceptable for the majority of people. Despite that, stopping medications until the right ones were found was common, often due to side effects and ineffectiveness. This suggests that, with adjustments to treatment plans, effective pain control is achievable for most PwMS with pain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/prm\/9981770","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:11:27Z","timestamp":1785345087000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pain Medication Use and Perceived Effectiveness in People With Multiple Sclerosis: A Mixed\u2010Methods Study"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6579-1136","authenticated-orcid":false,"given":"Mohammed Suleiman","family":"Obsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0942-0469","authenticated-orcid":false,"given":"Alice","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-3904","authenticated-orcid":false,"given":"Kristen","family":"Lefever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1820-6758","authenticated-orcid":false,"given":"A.","family":"Julie Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4336-0095","authenticated-orcid":false,"given":"L.","family":"Laura Laslett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2397-5930","authenticated-orcid":false,"given":"Baye","family":"Dagnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2807-0070","authenticated-orcid":false,"given":"V.","family":"Bruce Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-7472","authenticated-orcid":false,"given":"Ingrid van der","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"e_1_2_11_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.12.002"},{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520958369"},{"key":"e_1_2_11_3_2","doi-asserted-by":"crossref","DOI":"10.15586\/codon.multiplesclerosis.2017.ch4","volume-title":"Neuropathic Pain in Multiple Sclerosis\u2013Current Therapeutic Intervention and Future Treatment Perspectives","author":"Murphy K. L.","year":"2017"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6579-2"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10195-w"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pjnns.2014.07.009"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms957oa"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002136"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1757649"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106778"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.09.023"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.110837"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.09.013"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02496.x"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12569"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000449413"},{"key":"e_1_2_11_17_2","article-title":"Use of Cannabis in Patients With Multiple Sclerosis From Argentina","volume":"51","author":"Carnero C. E.","year":"2021","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12472-4"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506070947"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09739-x"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329508"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2023.04.012"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269215517745348"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05182-6"},{"key":"e_1_2_11_25_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14737175.2018.1510772","article-title":"A Review of the Effects of Baclofen and of THC:CBD Oromucosal Spray on Spasticity-Related Walking Impairment in Multiple Sclerosis","volume":"18","author":"Arroyo G. R.","year":"2018","journal-title":"Expert Review of Neurotherapeutics"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105740"},{"key":"e_1_2_11_27_2","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-04347-w","article-title":"A Randomized Trial on Efficacy of Purified Cannabidiol on Spasticity in Multiple Sclerosis Patients With Gait Problems: First Report in Iran","volume":"398","author":"Mousavi P.","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11091212"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1440678"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302468"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2015.03.001"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1054\/jpai.2001.23133"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.107.742775"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.4388"},{"key":"e_1_2_11_35_2","first-page":"92","article-title":"Good Reporting of a Mixed Methods Study (GRAMMS) Checklist","volume":"13","author":"O\u2019Cathain A.","year":"2008","journal-title":"Journal of Health Services Research & Policy"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/acm.0000000000000388"},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049732315617444"},{"key":"e_1_2_11_39_2","doi-asserted-by":"crossref","DOI":"10.4324\/9781315015484","volume-title":"Qualitative Analysis","author":"Ezzy D.","year":"2013"},{"key":"e_1_2_11_40_2","volume-title":"Qualitative Research Methods: A Health Focus","author":"Rice P. L.","year":"1999"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3776"},{"key":"e_1_2_11_42_2","volume-title":"Remote Areas Statistical Geography in Australia: Notes on the Accessibility\/Remoteness Index for Australia (ARIA+ Version)","author":"Glover J.","year":"2003"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.118115"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.96.15_supplement.4926"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjpain.2017.04.070"},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.8.1089"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.07.015"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01072-5"},{"key":"e_1_2_11_49_2","first-page":"1245","article-title":"Pharmacological Management of Pain in Patients With Multiple Sclerosis","volume":"70","author":"Solaro C.","year":"2010","journal-title":"Drugs"},{"key":"e_1_2_11_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9040919"},{"key":"e_1_2_11_51_2","article-title":"Central Pain in Patients With Multiple Sclerosis","volume":"4","author":"Feketov\u00e1 S.","year":"2017","journal-title":"Journal of Multiple Sclerosis"},{"key":"e_1_2_11_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.120"},{"key":"e_1_2_11_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)14738-1"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18472"},{"key":"e_1_2_11_55_2","article-title":"Cannabis and Cannabinoids for Symptomatic Treatment for People With Multiple Sclerosis","volume":"5","author":"Filippini G.","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_11_56_2","unstructured":"MurphyK. BetheaJ. andFischerR. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis: Neuropathic Pain in Multiple Sclerosis \u2013 Current Therapeutic Intervention and Future Treatment Perspectives 2017 https:\/\/exonpublications.com\/index.php\/exon\/article\/view\/153."},{"key":"e_1_2_11_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00660-0"},{"key":"e_1_2_11_58_2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0895-4356(94)90170-8","article-title":"Evidence of the Depletion of Susceptibles Effect in Non-Experimental Pharmacoepidemiologic Research","volume":"47","author":"Moride Y.","year":"1994","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Pain Research and Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/prm\/9981770","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/prm\/9981770","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/prm\/9981770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:11:31Z","timestamp":1785345091000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/prm\/9981770"}},"subtitle":[],"editor":[{"given":"Massimiliano","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/prm\/9981770"],"URL":"https:\/\/doi.org\/10.1155\/prm\/9981770","archive":["Portico"],"relation":{},"ISSN":["1203-6765","1918-1523"],"issn-type":[{"value":"1203-6765","type":"print"},{"value":"1918-1523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"9981770"}}